A tetracoordinate rhodium complex, Rh(C⋮CC 6 H 5 )(nbd)[P(C 6 H 5 ) 3 ] (nbd = 2,5-norbornadiene), combined with 4-(dimethylamino)pyridine (DMAP) is an excellent initiator for the stereospecific living polymerization of phenylacetylene and its m - and p -substituted derivatives. The rhodium initiator can be generated efficiently by dissociation of triphenylphosphine from isolable Rh(C⋮CC 6 H 5 )(nbd)[P(C 6 H 5 ) 3 ] 2 or by reacting Rh(CH 3 )(nbd)[P(C 6 H 5 ) 3 ] 2 or [Rh(OCH 3 )(nbd)] 2 /P(C 6 H 5 ) 3 with one equivalent of phenylacetylene. The use of a phenylethynyl group, triphenylphosphine, and NBD ligand attached to the rhodium center is crucial for the well-controlled polymerization of phenylacetylenes. An additive, DMAP, is necessary to attain low polydispersities of the polymer products. An active rhodium(I) complex bearing a growing polymer chain, NBD, and P(C 6 H 5 ) 3 was isolated from a reaction mixture and was characterized by NMR, GC−MS, XPS, and elemental analyses. The isolated active polymer initiates the further polymerization of the same monomer or substituted ones with an almost 100% initiation efficiency to give higher molecular weight homopolymers or block copolymers, respectively. Detailed NMR structural analysis of the products indicated that the polymerization with the rhodium(I) complexes proceeds via a 2,1-insertion mechanism to provide stereoregular poly(phenylacetylene)s with cis−transoidal backbone structure.
No takes yet. Share an insight, caveat, or question.
Kishimoto et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: